Cingulate Receives Complete Response Letter from FDA for CTx-1301
Go back to Cingulate Receives Complete Response Letter from FDA for CTx-1301| (NASDAQ: CING) | Delayed: 4.99 -0.13 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.12 | 52 Week High | $ | |||
| Open | $5.10 | 52 Week Low | $ | |||
| Day High | $5.23 | P/E | N/A | |||
| Day Low | $4.93 | EPS | $ | |||
| Volume | 506,499 | |||||
| (NASDAQ: CINGW) | Delayed: 0.02 -0.01 (33.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 31,248 | |||||
